These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31152320)

  • 1. Unintended Effects of Communicating About Drug Safety Issues: A Critical Review of the Literature.
    DeFrank JT; McCormack L; West SL; Lefebvre C; Burrus O
    Drug Saf; 2019 Oct; 42(10):1125-1134. PubMed ID: 31152320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDA drug safety communications: a narrative review and clinical considerations for older adults.
    Marcum ZA; Vande Griend JP; Linnebur SA
    Am J Geriatr Pharmacother; 2012 Aug; 10(4):264-71. PubMed ID: 22683398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review.
    Dusetzina SB; Higashi AS; Dorsey ER; Conti R; Huskamp HA; Zhu S; Garfield CF; Alexander GC
    Med Care; 2012 Jun; 50(6):466-78. PubMed ID: 22266704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Youth Risk Behavior Surveillance - United States, 2015.
    Kann L; McManus T; Harris WA; Shanklin SL; Flint KH; Hawkins J; Queen B; Lowry R; Olsen EO; Chyen D; Whittle L; Thornton J; Lim C; Yamakawa Y; Brener N; Zaza S
    MMWR Surveill Summ; 2016 Jun; 65(6):1-174. PubMed ID: 27280474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Industry challenge to best practice risk communication.
    McEntire J; Boateng A
    J Food Sci; 2012 Apr; 77(4):R111-7. PubMed ID: 22429296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-Cigarette Marketing and Communication: How E-Cigarette Companies Market E-Cigarettes and the Public Engages with E-cigarette Information.
    Collins L; Glasser AM; Abudayyeh H; Pearson JL; Villanti AC
    Nicotine Tob Res; 2019 Jan; 21(1):14-24. PubMed ID: 29315420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal Analysis of FDA Drug Safety Communications: Lessons from Zolpidem.
    Kesselheim AS; Sinha MS; Campbell EG; Schneeweiss S; Rausch P; Lappin BM; Zhou EH; Avorn J; Dal Pan GJ
    Drug Saf; 2019 Nov; 42(11):1287-1295. PubMed ID: 31302895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivering risk information in a dynamic information environment: Framing and authoritative voice in Centers for Disease Control (CDC) and primetime broadcast news media communications during the 2014 Ebola outbreak.
    Kott A; Limaye RJ
    Soc Sci Med; 2016 Nov; 169():42-49. PubMed ID: 27682022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Counseling in the clinical setting to prevent unintended pregnancy: an evidence-based research agenda.
    Moos MK; Bartholomew NE; Lohr KN
    Contraception; 2003 Feb; 67(2):115-32. PubMed ID: 12586322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The implementation of medical monitoring programs following potentially hazardous exposures: a medico-legal perspective.
    Vearrier D; Greenberg MI
    Clin Toxicol (Phila); 2017 Nov; 55(9):956-969. PubMed ID: 28644057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scaling Up Research on Drug Abuse and Addiction Through Social Media Big Data.
    Kim SJ; Marsch LA; Hancock JT; Das AK
    J Med Internet Res; 2017 Oct; 19(10):e353. PubMed ID: 29089287
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.